Author: Kherad, Omar; Kaiser, Laurent; Bridevaux, Pierre-Olivier; Sarasin, François; Thomas, Yves; Janssens, Jean-Paul; Rutschmann, Olivier T.
Title: Upper-Respiratory Viral Infection, Biomarkers, and COPD Exacerbations Cord-id: 7jnw66gk Document date: 2015_12_16
ID: 7jnw66gk
Snippet: BACKGROUND: Respiratory viruses frequently are recovered in the upper-respiratory tract during acute exacerbations of COPD (AECOPD), but their role as contributing pathogens remains unclear. The usefulness of procalcitonin and C-reactive protein as indicators of the presence or absence of viral infection in this setting also needs to be evaluated. METHODS: The study was of a prospective cohort of patients with COPD admitted to the ED for AECOPD. Reverse transcriptase-polymerase chain reaction (R
Document: BACKGROUND: Respiratory viruses frequently are recovered in the upper-respiratory tract during acute exacerbations of COPD (AECOPD), but their role as contributing pathogens remains unclear. The usefulness of procalcitonin and C-reactive protein as indicators of the presence or absence of viral infection in this setting also needs to be evaluated. METHODS: The study was of a prospective cohort of patients with COPD admitted to the ED for AECOPD. Reverse transcriptase-polymerase chain reaction (RT-PCR) for 14 respiratory viruses was performed on nasopharyngeal swabs collected at admission and after recovery in stable condition. RESULTS: Eighty-six patients (mean age, 72 years; male, 64%) were included. During AECOPD, upper-respiratory viral infections were detected in 44 (51%) patients: picornavirus in 22, metapneumovirus in seven, coronavirus in eight, influenza A/B in two, parainfluenza in two, and respiratory syncytial virus in three. A dual infection was present in three patients. After recovery, viruses were detected in only eight (11%) of 71 patients (P < .001 compared with AECOPD phase). In five of these patients, no virus had been identified during the initial exacerbation, thus suggesting a new viral infection acquired during follow-up. During AECOPD, procalcitonin and C-reactive protein levels did not differ significantly between patients with or without a proven viral infection. CONCLUSIONS: Prevalence of upper-respiratory viral infection, as detected from nasopharyngeal swab by RT-PCR, is high in AECOPD and low after clinical recovery, suggesting that AECOPD frequently are triggered by viral infections initiated in the upper-respiratory tract. In our study, serum procalcitonin and C-reactive protein did not discriminate virus-associated exacerbations from others. TRIAL REGISTRATION: clinicaltrials.gov; Identifier: NCT00448604.
Search related documents:
Co phrase search for related documents- absence presence and acute phase: 1, 2, 3, 4, 5, 6, 7, 8
- absence presence and acute pneumonia: 1, 2, 3, 4, 5, 6, 7
- absence presence and acute pulmonary embolism: 1, 2, 3, 4, 5
- absence presence and logistic regression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- absence presence and long period: 1, 2, 3, 4, 5
- absence presence and low airway: 1
- absence presence and low respiratory: 1
- acid detection and acute phase: 1, 2, 3
- acid detection and acute pneumonia: 1, 2, 3, 4, 5
- acid detection and logistic regression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- acid detection and long period: 1, 2, 3
- acid detection and low respiratory: 1, 2, 3, 4, 5
- acid detection and low respiratory tract: 1
- acute phase and logistic regression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute phase and long period: 1, 2, 3
- acute phase and low respiratory: 1
- acute pneumonia and logistic regression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute pneumonia and long period: 1, 2, 3, 4
- acute pneumonia and low respiratory: 1, 2, 3, 4, 5, 6, 7, 8
Co phrase search for related documents, hyperlinks ordered by date